EP1545554A4 - Verfahren und zusammensetzungen zur behandlung von diabetes mellitus - Google Patents

Verfahren und zusammensetzungen zur behandlung von diabetes mellitus

Info

Publication number
EP1545554A4
EP1545554A4 EP02756627A EP02756627A EP1545554A4 EP 1545554 A4 EP1545554 A4 EP 1545554A4 EP 02756627 A EP02756627 A EP 02756627A EP 02756627 A EP02756627 A EP 02756627A EP 1545554 A4 EP1545554 A4 EP 1545554A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
treating sugar
sugar diabetes
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02756627A
Other languages
English (en)
French (fr)
Other versions
EP1545554A1 (de
Inventor
Xiao Chen
Yun Sheng Li
Jing Li
Fang Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio University
Original Assignee
Ohio University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio University filed Critical Ohio University
Publication of EP1545554A1 publication Critical patent/EP1545554A1/de
Publication of EP1545554A4 publication Critical patent/EP1545554A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
EP02756627A 2002-07-24 2002-07-24 Verfahren und zusammensetzungen zur behandlung von diabetes mellitus Withdrawn EP1545554A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/023523 WO2004009094A1 (en) 2002-07-24 2002-07-24 Methods and compositions for treating diabetes mellitis

Publications (2)

Publication Number Publication Date
EP1545554A1 EP1545554A1 (de) 2005-06-29
EP1545554A4 true EP1545554A4 (de) 2006-06-14

Family

ID=30769029

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02756627A Withdrawn EP1545554A4 (de) 2002-07-24 2002-07-24 Verfahren und zusammensetzungen zur behandlung von diabetes mellitus

Country Status (6)

Country Link
EP (1) EP1545554A4 (de)
JP (1) JP2005538987A (de)
CN (1) CN1668311A (de)
AU (1) AU2002322623A1 (de)
CA (1) CA2496912A1 (de)
WO (1) WO2004009094A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8357796B2 (en) 2004-01-23 2013-01-22 Ohio University PGG separation and purification
JP2006056850A (ja) * 2004-08-23 2006-03-02 Suntory Ltd リパーゼ阻害剤
WO2006034468A2 (en) * 2004-09-23 2006-03-30 Ohio University Methods and compositions for treating hyperglycemic, hyperlipidemic, or hyperinsulinemic disorders
WO2009064082A1 (en) * 2007-11-13 2009-05-22 Igsbio Composition comprising galla rhois extract for prevention and treatment of obesity by means of autophagic mechanism
RU2487882C1 (ru) 2009-10-29 2013-07-20 Майлан Груп Галлотанниновые соединения в композициях для покрытия литографических печатных форм
JP6222626B2 (ja) * 2011-07-07 2017-11-01 長岡香料株式会社 フルクトース吸収阻害剤
JP2021505577A (ja) * 2017-12-07 2021-02-18 シニュークス インターナショナル（タイワン）コーポレイション タンニン酸組成物を調製するための改良された濃縮法
US11154531B2 (en) 2020-02-08 2021-10-26 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof
AU2021260663A1 (en) 2020-04-23 2022-11-10 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof
CN111905029A (zh) * 2020-08-26 2020-11-10 中国农业大学 一种含龙胆酸的药用组合及其应用
CN115813940A (zh) * 2022-11-17 2023-03-21 中国科学院西北高原生物研究所 党参中1,2,3,4,6-o-五没食子酰葡萄糖在制备降血糖药物方面的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000025787A1 (en) * 1998-10-30 2000-05-11 Guilford Pharmaceuticals Inc. Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
JP2002080362A (ja) * 2000-06-21 2002-03-19 Kao Corp Ｐｐａｒ依存的遺伝子転写活性化剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2380299A1 (fr) * 1977-02-09 1978-09-08 Gilbert Carraz Nouveau produit a activite hypoglycemiante et son procede de preparation
JPH0759515B2 (ja) * 1986-10-21 1995-06-28 株式会社ツムラ アルド−スリダクタ−ゼ阻害剤
KR19980074710A (ko) * 1997-03-21 1998-11-05 손경식 콜레스테롤 저하 약제 조성물
JP4873824B2 (ja) * 2000-08-01 2012-02-08 オリザ油化株式会社 糖質吸収阻害剤およびその製造方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000025787A1 (en) * 1998-10-30 2000-05-11 Guilford Pharmaceuticals Inc. Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
JP2002080362A (ja) * 2000-06-21 2002-03-19 Kao Corp Ｐｐａｒ依存的遺伝子転写活性化剤

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JIE ZHANG AND JIA-HE LI: "PARP and PARG as novel therapeutic targets", DRUGS OF THE FUTURE, vol. 27, no. 4, April 2002 (2002-04-01), pages 371 - 383, XP002378108 *
NONAKA ET AL.: "Tannins and Related Compounds. LVIII. Novel Gallotannins Possessing an alpha-Glucose Core from Nuphar japonicum DC", CHEM PHARM BULL, vol. 35, no. 8, 1987, pages 3127 - 3131, XP008084720 *
PATENT ABSTRACTS OF JAPAN vol. 2002, no. 07 3 July 2002 (2002-07-03) *
See also references of WO2004009094A1 *

Also Published As

Publication number Publication date
CN1668311A (zh) 2005-09-14
JP2005538987A (ja) 2005-12-22
EP1545554A1 (de) 2005-06-29
CA2496912A1 (en) 2004-01-29
AU2002322623A1 (en) 2004-02-09
WO2004009094A1 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
EP1755391A4 (de) Verfahren und zusammensetzungen zur behandlung von nervenleiden
EP1701725A4 (de) Verfahren und zusammensetzungen
EP1696877A4 (de) Verfahren zur schmerzbehandlung
MY143799A (en) Compositions and methods for treating diabetes
EP1858542A4 (de) Zusammensetzungen und verfahren zur behandlung von gefässpermeabilität
EP1663259A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP1571968A4 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von tumoren
ZA200703888B (en) Anti-glypican 3 antibody having modified sugar chain
EP1578996A4 (de) Zusammensetzungen und verfahren für die tumor-diagnose und behandlung
EP1562422A4 (de) Zusammensetzungen und verfahren für die verlängerung der überlebensdauer von blutplättchen
EP1662993A4 (de) Bioimpedanzverfahren und gerät
ITRM20040638A1 (it) Gel piastrinico semisintetico e metodo per la sua preparazione.
EP1796666A4 (de) Verfahren und zusammensetzungen zur behandlung von hyperlipidämie
EP1765260A4 (de) Desinfektionszusammensetzung und herstellungsverfahren
DK1620551T3 (da) Phospholipase og fremgangsmåde til fremstilling deraf
EP1931800A4 (de) Systeme und verfahren zur anreicherung von analyten
EP1578364A4 (de) Zusammensetzungen und verfahren zur behandlung von erkrankungen des immunsystems
EP1750594A4 (de) Gerät und verfahren zur durchführung einer gefässanastomose
DK1692102T3 (da) Sammensætninger og fremgangsmåder til at påvise og behandle sygdomme og tilstande knyttet til chemokinreceptorer
EP1545554A4 (de) Verfahren und zusammensetzungen zur behandlung von diabetes mellitus
EP1896625A4 (de) Vorrichtung und verfahren zum kontrollieren der dicke
EP1626711A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP1853159A4 (de) Verfahren und gerät zur bestimmung von blutanalyten
EP1774029A4 (de) Verfahren zum nachweis des risikos und zur behandlung von typ-2-diabetes
EP1682512A4 (de) Immunohistochemische verfahren

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050224

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20060512

17Q First examination report despatched

Effective date: 20060921

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091223